The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.
D000284:Administration, Oral; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004355:Drug Stability; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D009369:Neoplasms / Q000188:drug therapy*; D010212:Papilloma / Q000188:drug therapy; D012004:Rectal Neoplasms / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D001205:Ascorbic Acid